Melanoma vaccine (Institut Curie)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMelanoma vaccine (Institut Curie)

Drug Alias NameN/A

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionTyrosinase modulatorsMelanoma antigen recognized by T-cells 1 modulatorsBifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase modulators

TargetsTyrosinaseMelanoma antigen recognized by T-cells 1Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesInstitut Curie

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInstitut Curie

Active IndicationsN/A

Inactive IndicationsMelanoma

Other Information

ATC CodeN/A